New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 13, 2014
05:28 EDTINCYIncyte names Herve Hoppenot CEO
Incyte announced that Herve Hoppenot, former president of Novartis Oncology, has been named president and CEO of Incyte, effective immediately. Hoppenot, who also will join the Incyte board, succeeds Paul Friedman, M.D. Dr. Friedman is retiring and will continue to serve on the board.
News For INCY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 2, 2015
07:31 EDTINCYIncyte to present new data on immuno-oncology portfolio at SITC
Subscribe for More Information
October 1, 2015
07:31 EDTINCYLeerink to hold a roundtable
Subscribe for More Information
September 30, 2015
08:30 EDTINCYIncyte to join Nasdaq-100 Index beginning Oct. 7, to replace Altera
Nasdaq yesterday announced that Incyte Corporation (INCY), will become a component of the NASDAQ-100 Index and the NASDAQ-100 Equal Weighted Index prior to market open on Wednesday, October 7, 2015. Incyte Corporation will replace Altera Corporation (ALTR). Incyte Corporation is headquartered in Palo Alto, California, and has a market capitalization of approximately $19B.
September 29, 2015
06:47 EDTINCYEli Lilly and Incyte's baricitinib Phase 3 study met primary objective
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use